Suchergebnisse - "Rapaccini, Gian Ludovico"

1

On January 29, 2018, Corrado Colagrande passed away in Rome

von: Rapaccini, Gian Ludovico

2018, in: Journal of ultrasound

Wird geladen...
2

Effectiveness of Radiofrequency Ablation of Hepatocellular Carcinoma

von: Pompili, Maurizio

2009, in: World Journal of Surgery

Wird geladen...
3

Bridge Treatments of Hepatocellular Carcinoma in Cirrhotic Patients Submitted to Liver Transplantation

von: Pompili, Maurizio

2008, in: Digestive diseases and sciences

Wird geladen...
4

Acute hepatitis associated with use of paroxetine

von: Pompili, Maurizio

2008, in: Internal and emergency medicine

Wird geladen...
5

A case of non-occlusive mesenteric ischemia and hepatic portal venous gas: not everyone knows that…

von: Siciliani, Luisa

2011, in: Internal and emergency medicine

Wird geladen...
6

Tu1315 Loss of Response in IBD Patients on Infliximab Treatment: Assay of Infliximab Trough Levels and Total Antibodies to Infliximab

von: Guidi, Luisa

2015, in: Ubiquitin protease Ubp8 is necessary for

Wird geladen...
7

Tu1313 Infliximab Is More Effective Than Azathioprine in the Long-Term Prevention of Postoperative Recurrence of Crohn's Disease

von: Armuzzi, Alessandro

2015, in: Ubiquitin protease Ubp8 is necessary for

Wird geladen...
8

Free light chains: Eclectic multipurpose biomarker

von: Basile, Umberto

2017transfer abstract, in: 969: Cesarean prevalence rates overtime by maternal characteristics

Wird geladen...
9

IgG3 subclass: A possible trigger of mixed cryoglobulin cascade in hepatitis C virus chronic infection

von: Basile, Umberto

2017, in: The relationship between physical performance and cardiac function in an elderly Russian cohort

Wird geladen...
10

Real-time ultrasound guided renal biopsy in diffuse renal disease: 114 consecutive cases

von: Rapaccini, Gian Ludovico

1989, in: Surgical endoscopy and other interventional techniques

Wird geladen...
11

Sa1978 Infliximab Trough Levels After Dose Optimization for Loss of Response Predict Outcome at One Year

von: Guidi, Luisa

2016, in: Ubiquitin protease Ubp8 is necessary for

Wird geladen...
12

Free light chains and autoimmunity

von: Napodano, Cecilia

2019transfer abstract, in: Synthesis and anti-hepatitis B virus activity of acyclovir conjugated stearic acid-g-chitosan oligosaccharide micelle

Wird geladen...
13

342 Retreatment With Infliximab in Inflammatory Bowel Disease: Tolerability and Effectiveness of Different Re-Induction Regimens

von: Felice, Carla

2014, in: Ubiquitin protease Ubp8 is necessary for

Wird geladen...
14

Liver involvement in hereditary hemorrhagic telangiectasia: can breath test unmask impaired hepatic first-pass effect?

von: Candelli, Marcello

2011, in: Internal and emergency medicine

Wird geladen...
15

Abdominal angina due to recurrence of cancer of the papilla of Vater: a case report

von: Biolato, Marco

2009, in: Journal of medical case reports

Wird geladen...
16

Small (≤3 cm) hepatic lesions

von: Fornari, Fabio

1994, in: Digestive diseases and sciences

Wird geladen...
17

Clinical suspicion of pancreatic neoplasm: does echo-guided fine-needle biopsy modify patient management?

von: Rapaccini, Gian Ludovico

1990, in: Surgical endoscopy and other interventional techniques

Wird geladen...
18

Mo1539 Dynamic Contrast Enhanced Ultrasound Perfusion Imaging and Clinically Significant Portal Hypertension in Patients With Liver Cirrhosis: A Feasibility Study

von: Ainora, Maria Elena

2016, in: Ubiquitin protease Ubp8 is necessary for

Wird geladen...
19

491 Prediction of Clinical Response and Mucosal Healing At One Year by Faecal Calprotectin Assay After Induction With Anti-TNF Alpha Agents in IBD Patients

von: Guidi, Luisa

2013, in: Ubiquitin protease Ubp8 is necessary for

Wird geladen...
20

Different biochemical patterns in type II and type III mixed cryoglobulinemia in HCV positive patients

von: Basile, Umberto

2018, in: The relationship between physical performance and cardiac function in an elderly Russian cohort

Wird geladen...

Nicht das Richtige dabei?

Schreiben Sie uns!